<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>PROSTQA model-predicted probabilities of men having functional erections suitable for intercourse two years after brachytherapy for prostate cancer</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">PROSTQA model-predicted probabilities of men having functional erections suitable for intercourse two years after brachytherapy for prostate cancer</h1>
<div class="graphic"><div class="figure"><div class="ttl">PROSTQA model-predicted probabilities of men having functional erections suitable for intercourse two years after brachytherapy for prostate cancer</div><div class="cntnt"><table cellspacing="0"><colgroup width="5%"></colgroup><colgroup span="5" width="19%"></colgroup> <tbody> <tr> <td class="subtitle1" rowspan="2">Age, y</td> <td class="subtitle1" rowspan="2">Race/ethnicity*</td> <td class="subtitle1" rowspan="2">BMI<sup>¶</sup></td> <td class="subtitle1" colspan="3">Predicted functional erections after treatment, percent (95% CI) (by pretreatment sexual HRQOL score)<sup>Δ</sup></td> </tr> <tr> <td class="subtitle2">67</td> <td class="subtitle2">83</td> <td class="subtitle2">100</td> </tr> <tr> <td class="divider_bottom" rowspan="6">60</td> <td class="divider_bottom" rowspan="3">African American</td> <td>&lt;25</td> <td>78 (48-94)</td> <td>92 (73-98)</td> <td>98 (89-99)</td> </tr> <tr> <td>25-&lt;35</td> <td>61 (35-83)</td> <td>83 (62-94)</td> <td>94 (83-98)</td> </tr> <tr class="divider_bottom"> <td>≥35</td> <td>28 (7-69)</td> <td>56 (18-88)</td> <td>81 (41-96)</td> </tr> <tr> <td class="divider_bottom" rowspan="3">White/other</td> <td>&lt;25</td> <td>54 (33-74)</td> <td>79 (61-90)</td> <td>93 (83-97)</td> </tr> <tr> <td>25-&lt;35</td> <td>34 (22-48)</td> <td>62 (50-73)</td> <td>85 (75-91)</td> </tr> <tr class="divider_bottom"> <td>≥35</td> <td>11 (3-37)</td> <td>29 (9-63)</td> <td>58 (24-86)</td> </tr> <tr> <td class="divider_bottom" rowspan="6">65</td> <td class="divider_bottom" rowspan="3">African American</td> <td>&lt;25</td> <td>73 (41-91)</td> <td>89 (67-97)</td> <td>97 (86-99)</td> </tr> <tr> <td>25-&lt;35</td> <td>54 (28-77)</td> <td>79 (54-92)</td> <td>93 (77-98)</td> </tr> <tr class="divider_bottom"> <td>≥35</td> <td>22 (5-62)</td> <td>48 (14-84)</td> <td>76 (33-95)</td> </tr> <tr> <td class="divider_bottom" rowspan="3">White/other</td> <td>&lt;25</td> <td>46 (28-66)</td> <td>73 (55-86)</td> <td>90 (79-96)</td> </tr> <tr> <td>25-&lt;35</td> <td>27 (18-39)</td> <td>54 (44-65)</td> <td>80 (69-88)</td> </tr> <tr class="divider_bottom"> <td>≥35</td> <td>9 (2-30)</td> <td>23 (6-56)</td> <td>50 (18-82)</td> </tr> <tr> <td rowspan="6">70</td> <td class="divider_bottom" rowspan="3">African American</td> <td>&lt;25</td> <td>66 (34-88)</td> <td>86 (60-96)</td> <td>95 (81-99)</td> </tr> <tr> <td>25-&lt;35</td> <td>46 (21-73)</td> <td>73 (45-90)</td> <td>90 (70-97)</td> </tr> <tr class="divider_bottom"> <td>≥35</td> <td>17 (3-56)</td> <td>40 (10-80)</td> <td>69 (25-94)</td> </tr> <tr> <td rowspan="3">White/other</td> <td>&lt;25</td> <td>39 (22-58)</td> <td>67 (47-82)</td> <td>87 (72-95)</td> </tr> <tr> <td>25-&lt;35</td> <td>22 (13-33)</td> <td>47 (34-60)</td> <td>75 (60-86)</td> </tr> <tr> <td>≥35</td> <td>6 (1-25)</td> <td>18 (4-50)</td> <td>42 (13-78)</td> </tr> </tbody></table></div><div class="graphic_footnotes">PROSTQA: Prostate Cancer Outcomes and Satisfaction With Treatment Quality Assessment; BMI: body mass index; HRQOL: health-related quality of life.<br/>* White race/ethnicity included 3 percent of patients of other (non-African American) or unknown races/ethnicities.<br/>¶ Calculated as weight in kilograms divided by height in meters squared.<br/>Δ Specific values of pretreatment sexual functioning (Expanded Prostate Cancer Index Composite scores of 67, 83, and 100; range of 0-100, with a higher score representing better function) are tabulated to represent cohort distribution (25th, 50th, and 75th percentiles of scores among prostatectomy-treated patients) as well as to reflect a clinically relevant set of possible pretreatment sexual functioning. These values correspond to the 45th, 60th, and 85th percentiles among patients treated with brachytherapy. Across all treatment groups, these percentiles correspond to 358 patients (36 percent) with pretreatment sexual HRQOL scores of 67 or less, 441 (45 percent) with scores of 68-99, and 186 (19 percent) with scores of 100.</div><div class="graphic_reference">Reproduced with permission from: Alemozaffar M, Regan MM, Cooperberg MR, et al. Prediction of erectile function following treatment for prostate cancer. JAMA 2011; 306:1205. Copyright © 2011 American Medical Association. All rights reserved.</div><div id="graphicVersion">Graphic 82368 Version 22.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
